Vertaling van "years of follow-up " (Frans → Nederlands) :

First and most important, for symptomatic stenosis patients, the number needed to treat to benefit within two years is between 3 to 19, depending on degree of stenosis and age. 15 For asymptomatic stenosis, as the Kaplan Mayer-curve suggests, at least five years of follow-up are needed to recoup the lost life years by increased morbidity and mortality (see further).
First and most important, for symptomatic stenosis patients, the number needed to treat to benefit within two years is between 3 to 19, depending on degree of stenosis and age.15 For asymptomatic stenosis, as the Kaplan Mayer-curve suggests, at least five years of follow-up are needed to recoup the lost life years by increased morbidity and mortality (see further).

49. Miller Ab TTBCJWC. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.
50. Miller Ab TTBCJWC. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.

Johnson CE, Lim WK, Workman BS. People aged over 75 in atrial fibrillation on warfarin: the rate of major hemorrhage and stroke in more than 500 patient-years of follow up.
Singer DE, Chang Y, Fang MC et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation.

21. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.
20. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.

20. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.
19. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.

Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. preventive services task force.

Lewis JR, Calver J, Zhu K, et al. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5 year follow-up.
Singh S, Furberg CD. Systematic review: Calcium supplements increase risk of myocardial infarction.

44. Ro K, Gude T, Tyssen R, Aasland O. A self-referral preventive intervention for burnout among Norwegian nurses: One-year follow-up study.
45. Ro K, Gude T, Tyssen R, Aasland O. A self-referral preventive intervention for burnout among Norwegian nurses: One-year follow-up study.

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Breast cancer and hormone-replacement therapy in the million Women Study.

At 7 y follow up : AR* : RR: 0.94 (0.78, 1.14) SR:RR: 0.81(0.63, 1.05) All : RR: 0.89(0.77, 1.04) At 13 y follow up AR :RR: 0.90 (0.79, 1.02) Sub.R :RR: 0.75 (0.67, 0.83) All :RR: 0.84(0.74, 0.096)
At 7 y follow up : AR* : RR: 0.94 (0.78, 1.14) SR:RR: 0.81(0.63, 1.05) All : RR: 0.89(0.77, 1.04) At 13 y follow up AR :RR: 0.90 (0.79, 1.02) Sub.R :RR: 0.75 (0.67, 0.83) All :RR: 0.81(0.74, 0.87)